Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000039

CEO bought 52,000 shares at an average $0.01 ($636)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-13 Purchase : show line 1 in the form +11,000 $0.01 $131 24,313,097 D
2019-06-13 Purchase : show line 2 in the form +11,000 $0.01 $133 24,324,097 D
2019-06-14 Purchase : show line 3 in the form +11,000 $0.01 $134 24,335,097 D
2019-06-17 Purchase : show line 4 in the form +2,000 $0.01 $26 24,337,097 D
2019-06-17 Purchase : show line 5 in the form +5,000 $0.01 $62 24,342,097 D
2019-06-17 Purchase : show line 6 in the form +5,000 $0.01 $63 24,347,097 D
2019-06-17 Purchase : show line 7 in the form +5,000 $0.01 $62 24,352,097 D
2019-06-17 Purchase : show line 8 in the form +2,000 $0.01 $25 24,354,097 D
Open-market purchases · 52,000 sh · avg $0.01 · $636
Loading xslF345X03/primary_doc.xml…